Compare Thomson Reuters Corp (TRI) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Thomson Reuters Corp vs 22nd Century Group Inc — how do they compare? Thomson Reuters Corp trades at $101.97 (market cap $45.38B), while 22nd Century Group Inc trades at $4.38 (market cap $1.52M). The key difference: Thomson Reuters Corp is far larger — about 29855.3× 22nd Century Group Inc's market cap, and Thomson Reuters Corp pays a 2.5% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals.
| TRI | XXII | |
|---|---|---|
Market Cap | $45.38B | $1.52M |
Sector | Industrials | Technology |
52-Week High | $178.77 | $801.00 |
52-Week Low | $76.55 | $3.72 |
Enterprise Value | $48.00B | -$6.71M |
Dividend Yield | 2.5% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Thomson Reuters (TRI) trades at $102.46, down 1.82% on the day, with a bullish technical signal supported by moving averages. The company reported Q2 2026 EPS of $0.99, beating estimates, and raised full-year revenue guidance, driven by 8% organic growth in its Legal, Corporates, and Tax segments. Valuation metrics show a P/E of 27.61 and net income margin of 21.22%, with strong profitability and a dividend yield supported by recent $0.66 payouts.
Outlook remains positive due to robust recurring revenue and AI-driven product momentum, though risks include execution challenges in technology integration and competitive pressures. Analysts project a 29.8% upside to the consensus price target of $124.00, with 52% recommending Buy. Investors should weigh solid fundamentals against macroeconomic and sector-specific headwinds.
XXII trades at $4.38, up 0.69% with neutral technical signals. The company shows concerning fundamentals with negative profit margins (-65.76% net income margin) and ROE of -130.19%, though valuation ratios appear low (P/S 0.03, P/B 0.07). Recent corporate actions include a 20:1 reverse stock split in June 2026. Analyst sentiment remains positive with 75% buy ratings, while the company expands VLN® product distribution in key markets like California and New York.
The outlook remains speculative given persistent losses despite revenue generation. Investment opportunity lies in successful execution of reduced-nicotine cigarette expansion and FDA regulatory progress. Key risks include continued cash burn, competitive pressures, and dependency on regulatory approvals for growth catalysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Thomson Reuters Corp
Thomson Reuters is the result of the $17.6 billion megamerger of Canada's Thomson and the United Kingdom's Reuters Group in 2008 and the 2018 carve-out of its finance and risk business, Refinitiv, in which it holds a 45% stake. In 2019, the company agreed to exchange its 45% stake in Refinitiv for a 15% stake in LSE, which closed in early 2021. Since the divestiture, the company is more concentrated on selling its flagship legal data and software, Westlaw, and its tax accounting software, Onesource. Reuters sees roughly 80% of revenue and 70% of expenses attributed to the United States, while the remainder (largely through the global print and Reuters News segments) is distributed across Latin America, Europe, the Middle East, Africa, and Asia-Pacific.
Read more on TRI →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
